Further examination of these five SNPs using different CRP cutoffs to define high chronic inflammation revealed evidence of nominally significant interactions (p < 0.05) between high CRP levels (9–12 mg/L) and SNPs in CLU, SPI1 and CD33 for AD risk (p < 0.05) (Table S4). The gene discussed is CLU; the disease is Alzheimer disease.